29 results
8-K
EX-1.1
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
subsidiaries, or any contract, commitment, agreement, understanding or arrangement of any kind relating to the issuance of any capital stock of the Company
8-K
EX-5.1
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
in accordance with their terms without the breach or violation of any other agreement, commitment or obligation of the Company.
This opinion
424B5
NRIX
Nurix Therapeutics Inc
12 Apr 24
Prospectus supplement for primary offering
5:10pm
are sold by us to an underwriter in a firm commitment underwritten offering. The applicable prospectus supplement may provide that the original issue date
424B5
NRIX
Nurix Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:06pm
such trade expressly agree otherwise or the securities are sold by us to an underwriter in a firm commitment underwritten offering. The applicable prospectus
8-K
EX-3.1
nba d83hwwe
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
EX-5.1
40dk1t
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
424B5
ttbvo3m4er3tugjsji
8 Jul 22
Prospectus supplement for primary offering
4:10pm
424B5
665i3ceb el
8 Jul 22
Prospectus supplement for primary offering
4:09pm
S-3ASR
cggfoi8oem1l w90
4 Aug 21
Automatic shelf registration
4:11pm
S-3ASR
EX-1.2
r25dieq2u0o1e3
4 Aug 21
Automatic shelf registration
4:11pm
8-K
EX-99.1
va2 oht6e
26 Oct 20
Nurix Therapeutics Announces Appointment of Robert Tjian as Chairman of Scientific Advisory Board and His Resignation from the Board of Directors
4:05pm